Patient and Healthcare Provider Perspectives on the Pathway to Diagnosis of Seborrheic Dermatitis in the United States.

Pathway to diagnosis Patient survey Seborrheic dermatitis

Journal

Advances in therapy
ISSN: 1865-8652
Titre abrégé: Adv Ther
Pays: United States
ID NLM: 8611864

Informations de publication

Date de publication:
30 Sep 2024
Historique:
received: 06 07 2024
accepted: 29 08 2024
medline: 30 9 2024
pubmed: 30 9 2024
entrez: 30 9 2024
Statut: aheadofprint

Résumé

Seborrheic dermatitis (SD) is a common, chronic inflammatory skin condition associated with significant impact on quality of life, yet its etiology and pathophysiology are not well understood. With significant impact on patients' quality of life, understanding the diagnostic pathway from the perspectives of patient and healthcare providers (HCPs) is crucial. An online survey was developed and administered in conjunction with the Harris Poll to gain insight into patient and HCP perspectives about SD diagnosis and management from December 2021 to January 2022. Most patients were unaware of SD before their diagnosis (71%) and experienced difficulty finding information online (56%). Patients delayed seeking medical attention for SD by an average of 3.6 years, with most patients feeling their symptoms did not require medical attention (63%), a perception that HCPs correctly anticipated. Additionally, most patients (58%) reported embarrassment discussing their SD symptoms with HCPs, a factor HCPs underestimated. HCPs also underestimated the percentage of patients self-reporting moderate-severity SD. Patients preferred dermatology HCPs for SD treatment (79%), and reported visiting an average of 2.3 different HCPs, with 75% of patients seeing more than one provider. These insights highlight the complexities in the diagnostic and management pathways of SD and underscore the need for a more nuanced understanding and approach in addressing the condition. Infographic available for this article. INFOGRAPHIC.

Identifiants

pubmed: 39347927
doi: 10.1007/s12325-024-02986-8
pii: 10.1007/s12325-024-02986-8
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s).

Références

Polaskey MT, Chang CH, Daftary K, Fakhraie S, Miller CH, Chovatiya R. The global prevalence of seborrheic dermatitis: a systematic review and meta-analysis. JAMA Dermatol. 2024;160(8):846–855. https://doi.org/10.1001/jamadermatol.2024.1987 .
doi: 10.1001/jamadermatol.2024.1987 pubmed: 38958996
Haq Z, Abdi P, Wan V, Diaz MJ, Aflatooni S, Mirza FN, et al. Epidemiology of seborrheic dermatitis among adults in the United States: a cross-sectional analysis. Arch Dermatol Res. 2024;316(7):394.
doi: 10.1007/s00403-024-02900-w pubmed: 38878108
Peyrí J, Lleonart M. Clinical and therapeutic profile and quality of life of patients with seborrheic dermatitis. Actas Dermosifiliogr. 2007;98(7):476–82.
doi: 10.1016/S0001-7310(07)70111-4 pubmed: 17669302
Araya M, Kulthanan K, Jiamton S. Clinical Characteristics and quality of life of seborrheic dermatitis patients in a tropical country. Indian J Dermatol. 2015;60(5):519.
doi: 10.4103/0019-5154.164410 pubmed: 26538714 pmcid: 4601435
Szepietowski JC, Reich A, Wesołowska-Szepietowska E, Baran E. Quality of life in patients suffering from seborrheic dermatitis: influence of age, gender and education level. Mycoses. 2009;52(4):357–63.
doi: 10.1111/j.1439-0507.2008.01624.x pubmed: 18793259
Pärna E, Aluoja A, Kingo K. Quality of life and emotional state in chronic skin disease. Acta Derm Venereol. 2015;95(3):312–6.
doi: 10.2340/00015555-1920 pubmed: 24978135
Jackson JM, Alexis A, Zirwas M, Taylor S. Unmet needs for patients with seborrheic dermatitis. J Am Acad Dermatol. 2024;90(3):597–604.
doi: 10.1016/j.jaad.2022.12.017 pubmed: 36538948
Dessinioti C, Katsambas A. Seborrheic dermatitis: etiology, risk factors, and treatments: facts and controversies. Clin Dermatol. 2013;31(4):343–51.
doi: 10.1016/j.clindermatol.2013.01.001 pubmed: 23806151
Wikramanayake TC, Borda LJ, Miteva M, Paus R. Seborrheic dermatitis-looking beyond Malassezia. Exp Dermatol. 2019;28(9):991–1001.
doi: 10.1111/exd.14006 pubmed: 31310695
Dall’Oglio F, Nasca MR, Gerbino C, Micali G. An overview of the diagnosis and management of seborrheic dermatitis. Clin Cosmet Investig Dermatol. 2022;15:1537–48.
doi: 10.2147/CCID.S284671 pubmed: 35967915 pmcid: 9365318
Quiroz-Vergara JC, Morales-Sánchez MA, Castillo-Rojas G, López-Vidal Y, Peralta-Pedrero ML, Jurado-Santa Cruz F, et al. Diagnóstico tardío de psoriasis: motivos y consecuencias. Gac Med Mex. 2017;153(3):335–43.
pubmed: 28763072
Swetter SM, Soon S, Harrington CR, Chen SC. Effect of health care delivery models on melanoma thickness and stage in a university-based referral center: an observational pilot study. Arch Dermatol. 2007;143(1):30–6.
doi: 10.1001/archderm.143.1.30 pubmed: 17224539
Baade PD, English DR, Youl PH, McPherson M, Elwood JM, Aitken JF. The relationship between melanoma thickness and time to diagnosis in a large population-based study. Arch Dermatol. 2006;142(11):1422–7.
doi: 10.1001/archderm.142.11.1422 pubmed: 17116832
Scott S, Walter F. Studying help-seeking for symptoms: the challenges of methods and models. Soc Personal Psychol Compass. 2010;4(8):531–47. https://doi.org/10.1111/j.1751-9004.2010.00287.x .
doi: 10.1111/j.1751-9004.2010.00287.x
Richard MA, Paul C, Nijsten T, Gisondi P, Salavastru C, Taieb C, et al. The journey of patients with skin diseases from the first consultation to the diagnosis in a representative sample of the European general population from the EADV burden of skin diseases study. J Eur Acad Dermatol Venereol. 2023;37(Suppl 7):17–24.
doi: 10.1111/jdv.18916 pubmed: 37806003
Bahalah SO. Beliefs, attitudes, and treatment-seeking behavior among patients with acne vulgaris: a cross-sectional study from Yemen. Gulf J Dermatol Venereol. 2017;24(2):9–14. https://www.gulfdermajournal.net/pdf/2017-10/2.pdf .
Wisuthsarewong W, Nitiyarom R, Kanchanapenkul D, Arunkajohnask S, Limphoka P, Boonchai W. Acne beliefs, treatment-seeking behaviors, information media usage, and impact on daily living activities of Thai acne patients. J Cosmet Dermatol. 2020;19(5):1191–5.
doi: 10.1111/jocd.13132 pubmed: 31498553
Suh DH, Shin JW, Min SU, Lee DH, Yoon MY, Kim NI, et al. Treatment-seeking behaviors and related epidemiological features in Korean acne patients. J Korean Med Sci. 2008;23(6):969–74.
doi: 10.3346/jkms.2008.23.6.969 pubmed: 19119438 pmcid: 2610661
Sampogna F, Linder D, Piaserico S, Altomare G, Bortune M, Calzavara-Pinton P, et al. Quality of life assessment of patients with scalp dermatitis using the Italian version of the Scalpdex. Acta Derm Venereol. 2014;94(4):411–4.
doi: 10.2340/00015555-1731 pubmed: 24287710
Xuan M, Lu C, He Z. Clinical characteristics and quality of life in seborrheic dermatitis patients: a cross-sectional study in China. Health Qual Life Outcomes. 2020;18(1):308.
doi: 10.1186/s12955-020-01558-y pubmed: 32938485 pmcid: 7493366
Chovatiya R, Lei D, Ahmed A, Chavda R, Gabriel S, Silverberg JI. Clinical phenotyping of atopic dermatitis using combined itch and lesional severity: a prospective observational study. Ann Allergy Asthma Immunol. 2021;127(1):83-90.e2.
doi: 10.1016/j.anai.2021.03.019 pubmed: 33819616
Fakhraie S, Erickson T, Chovatiya R. Evaluation of a patient education platform for seborrheic dermatitis. Arch Dermatol Res. 2023;315(10):2927–30.
doi: 10.1007/s00403-023-02681-8 pubmed: 37500910
Wolf JA, Moreau JF, Patton TJ, Winger DG, Ferris LK. Prevalence and impact of health-related internet and smartphone use among dermatology patients. Cutis. 2015;95(6):323–8.
pubmed: 26125208
Saxena A, Dey VK, Srivastava P, et al. Treatment-seeking behavior of patients attending department of dermatology in a tertiary care hospital and their impact on disease. Med J Dr DY Patil Vidyapeeth. 2023;16(2):167–72. https://doi.org/10.4103/mjdrdypu.mjdrdypu_123_21 .
doi: 10.4103/mjdrdypu.mjdrdypu_123_2
Wallhed Finn S, Mejldal A, Baskaran R, Nielsen AS. Effects of media campaign videos on stigma and attitudes towards treatment seeking for alcohol use disorder: a randomized controlled study. BMC Public Health. 2023;23(1):1919.
doi: 10.1186/s12889-023-16811-4 pubmed: 37794390 pmcid: 10552234
Jagota P, Jongsuntisuk P, Plengsri R, Chokpatcharavate M, Phokaewvarangkul O, Chirapravati V, et al. If your patients were too embarrassed to go out in public, what would you do? - Public education to break the stigma on Parkinson’s disease using integrated media. Patient Relat Outcome Meas. 2020;11:143–8.
doi: 10.2147/PROM.S243990 pubmed: 32848490 pmcid: 7429227
Betton V, Borschmann R, Docherty M, Coleman S, Brown M, Henderson C. The role of social media in reducing stigma and discrimination. Br J Psychiatry. 2015;206(6):443–4.
doi: 10.1192/bjp.bp.114.152835 pubmed: 26034176
Berk T, Scheinfeld N. Seborrheic dermatitis. P T. 2010;35(6):348–52.
pubmed: 20592880 pmcid: 2888552
Clark GW, Pope SM, Jaboori KA. Diagnosis and treatment of seborrheic dermatitis. Am Fam Physician. 2015;91(3):185–90.
pubmed: 25822272

Auteurs

Raj Chovatiya (R)

Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA. raj.chovatiya@gmail.com.
Center for Medical Dermatology + Immunology Research, Chicago, IL, USA. raj.chovatiya@gmail.com.
, 3000 N Halsted Suite 301, Chicago, IL, 60657, USA. raj.chovatiya@gmail.com.

Meredith T Polaskey (MT)

Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA.

Lakshi Aldredge (L)

Veterans Administration Portland Health Care System, Portland, OR, USA.

Candrice Heath (C)

Temple University, Philadelphia, PA, USA.

Moises Acevedo (M)

Infinity Dermatology, New York, NY, USA.

David H Chu (DH)

Arcutis Biotherapeutics, Inc., Westlake Village, CA, USA.

Diane Hanna (D)

Arcutis Biotherapeutics, Inc., Westlake Village, CA, USA.

Melissa S Seal (MS)

Arcutis Biotherapeutics, Inc., Westlake Village, CA, USA.

Matthew Zirwas (M)

Dermatologists of Central States, Probity Medical Research, and Ohio University, Bexley, OH, USA.

Classifications MeSH